retatrutide daily or weekly Injection: Package Insert / Prescribing Info Retatrutide Dosing: Weekly Injections, Clinical

In the landmark SURMOUNT-1 trial , published in the New England Journal of Medicine in 2022, adults without diabetes taking the 15mg dose lost an average of 22.5% of their starting body weight over 72 weeks

Possible effect modification by age, sex, diabetes status, glycemic control, obesity, CVD, and other comorbidities, as well as compounds, administration methods, and dosages of GLP-1 RAs should be evaluated

BPC-157 demonstrates particular affinity for tendon tissue, with multiple studies showing accelerated tendon healing in animal models

(Islam et al., 2017) discovered that anthocyanin-rich strawberry extract is able to induce apoptosis, inhibit glycolysis, and significantly reduce ECM components, namely, collagen 1A1, fibronectin, and versican in leiomyoma cells